Hye-Young Min[Author] - Search Results

Year	Number of Results
2002	1
2003	3
2004	8
2005	9
2006	2
2007	5
2008	5
2009	3
2010	3
2011	5
2012	4
2013	3
2014	3
2015	8
2016	6
2017	2
2018	6
2019	3
2020	7
2021	6
2022	7
2023	13
2024	1

1

Molecular targeted therapy for anticancer treatment.

Min HY, Lee HY. Min HY, et al. Exp Mol Med. 2022 Oct;54(10):1670-1694. doi: 10.1038/s12276-022-00864-3. Epub 2022 Oct 12. Exp Mol Med. 2022. PMID: 36224343 Free PMC article. Review.

2

Oncogene-Driven Metabolic Alterations in Cancer.

Min HY, Lee HY. Min HY, et al. Biomol Ther (Seoul). 2018 Jan 1;26(1):45-56. doi: 10.4062/biomolther.2017.211. Biomol Ther (Seoul). 2018. PMID: 29212306 Free PMC article. Review.

3

RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse.

Cho J, Min HY, Lee HJ, Hyun SY, Sim JY, Noh M, Hwang SJ, Park SH, Boo HJ, Lee HJ, Hong S, Park RW, Shin YK, Hung MC, Lee HY. Cho J, et al. Among authors: min hy. J Clin Invest. 2023 May 15;133(10):e171901. doi: 10.1172/JCI171901. J Clin Invest. 2023. PMID: 37183821 Free PMC article. No abstract available.

4

Particulate matter-induced metabolic recoding of epigenetics in macrophages drives pathogenesis of chronic obstructive pulmonary disease.

Noh M, Sim JY, Kim J, Ahn JH, Min HY, Lee JU, Park JS, Jeong JY, Lee JY, Lee SY, Lee HJ, Park CS, Lee HY. Noh M, et al. Among authors: min hy. J Hazard Mater. 2024 Feb 15;464:132932. doi: 10.1016/j.jhazmat.2023.132932. Epub 2023 Nov 4. J Hazard Mater. 2024. PMID: 37988864

5

Cellular Dormancy in Cancer: Mechanisms and Potential Targeting Strategies.

Min HY, Lee HY. Min HY, et al. Cancer Res Treat. 2023 Jul;55(3):720-736. doi: 10.4143/crt.2023.468. Epub 2023 Mar 22. Cancer Res Treat. 2023. PMID: 36960624 Free PMC article. Review.

6

Dual Impact of IGF2 on Alveolar Stem Cell Function during Tobacco-Induced Injury Repair and Development of Pulmonary Emphysema and Cancer.

Boo HJ, Min HY, Park CS, Park JS, Jeong JY, Lee SY, Kim WY, Lee JW, Oh SR, Park RW, Lee HY. Boo HJ, et al. Among authors: min hy. Cancer Res. 2023 Jun 2;83(11):1782-1799. doi: 10.1158/0008-5472.CAN-22-3543. Cancer Res. 2023. PMID: 36971490

7

Effect of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and benzo[a]pyrene exposure on the development of metabolic syndrome in mice.

Jang HJ, Boo HJ, Min HY, Kang YP, Kwon SW, Lee HY. Jang HJ, et al. Among authors: min hy. Life Sci. 2023 Sep 15;329:121925. doi: 10.1016/j.lfs.2023.121925. Epub 2023 Jul 8. Life Sci. 2023. PMID: 37423377

8

Mechanisms of resistance to chemotherapy in non-small cell lung cancer.

Min HY, Lee HY. Min HY, et al. Arch Pharm Res. 2021 Feb;44(2):146-164. doi: 10.1007/s12272-021-01312-y. Epub 2021 Feb 19. Arch Pharm Res. 2021. PMID: 33608812 Review.

9

Ninjurin1 drives lung tumor formation and progression by potentiating Wnt/β-Catenin signaling through Frizzled2-LRP6 assembly.

Hyun SY, Min HY, Lee HJ, Cho J, Boo HJ, Noh M, Jang HJ, Lee HJ, Park CS, Park JS, Shin YK, Lee HY. Hyun SY, et al. Among authors: min hy. J Exp Clin Cancer Res. 2022 Apr 8;41(1):133. doi: 10.1186/s13046-022-02323-3. J Exp Clin Cancer Res. 2022. PMID: 35395804 Free PMC article.

10

The tobacco-specific carcinogen NNK induces pulmonary tumorigenesis via nAChR/Src/STAT3-mediated activation of the renin-angiotensin system and IGF-1R signaling.

Boo HJ, Min HY, Hwang SJ, Lee HJ, Lee JW, Oh SR, Park CS, Park JS, Lee YM, Lee HY. Boo HJ, et al. Among authors: min hy. Exp Mol Med. 2023 Jun;55(6):1131-1144. doi: 10.1038/s12276-023-00994-2. Epub 2023 Jun 1. Exp Mol Med. 2023. PMID: 37258578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year